Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer.
Lana E KhalilXingyu GaoJeffrey M SwitchenkoOlatunji B AleseMehmet AkceChristina WuMaria DiabBassel F El-RayesWalid L ShaibPublished in: The oncologist (2022)
Any adjuvant chemotherapy has a trend of survival benefits. Multi-agent chemotherapy seems to have an enhanced benefit in the 70-75 age group. Multi-agent chemotherapy seemed to have similar efficacy as SAC in those aged >76 years.